Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 16.24 | N/A |
| PEG Ratio (TTM) | 0.37 | N/A |
| P/S Ratio (TTM) | 1.22 | N/A |
| P/B Ratio (TTM) | 2.03 | N/A |
| P/FCF Ratio (TTM) | 2.41 | N/A |
| Price to 5YR AVG Earnings Ratio | 0.22 | N/A |
| Price to 5YR AVG FCF Ratio | 0.03 | N/A |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.35% | N/A |
| ROE (TTM) | 14.86% | N/A |
| Net Profit Margin (TTM) | 7.53% | N/A |
| ROIC 5YR AVG | 543.42% | N/A |
Growth (100%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 147.65% | 71.13% | 120.27% |
| Revenue | 51.45% | 61.22% | 139.79% |
| Net Income | 147.67% | 71.13% | 120.27% |
| Cash Flow | 223.04% | 364.52% | 306.48% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.02 | N/A |
| Interest Coverage (TTM) | 0.00 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.25 | N/A |
| LTL to 5YR AVG FCF | 0.41 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.00% | N/A |